SMD Rise PCL

SMD Rise PCL Financial Leverage

The Financial Leverage (Equity Multiplier) of SMD Rise PCL (SMD100.BK) as of Oct 20, 2026 is 1.95. In the previous year, Financial Leverage (Equity Multiplier) was 1.70 — a change of 14.96% (higher).

Financial Leverage

1.95

YoY

14.96%

Last updated:

Financial Leverage (Equity Multiplier) of SMD Rise PCL is 2025 1.95 . Financial Leverage (Equity Multiplier) of SMD Rise PCL was 2024 1.70 . It decreases by 14.96% higher compared to the previous year.

The SMD Rise PCL Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
2.50 THB
Jan 1, 2019
1.97 THB
Jan 1, 2020
2.87 THB
Jan 1, 2021
1.53 THB
Jan 1, 2022
1.18 THB
Jan 1, 2023
1.20 THB
Jan 1, 2024
1.70 THB
Jan 1, 2025
1.95 THB
The SMD Rise PCL Financial Leverage history
YEARFinancial LeverageYoY
1.95+14.96%
1.70+41.61%
1.20+1.86%
1.18-23.20%
1.53-46.58%
2.87+45.83%
1.97-21.14%
2.50-14.92%
2.93-15.86%
3.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL distributes medical devices and equipment, specializing in respiratory system products. The company imports and distributes medical equipment, supplies, and provides sleep monitoring services. It focuses on sleep disorders like obstructive sleep apnea (OSA), offering counseling and advice on CPAP devices for treatment. The firm targets patients with high blood pressure, diabetes, obesity, and various sleep issues including snoring, insomnia, and daytime sleepiness. Its subsidiary Saint Medical Trading Co.,Ltd handles additional distribution activities. The company generates revenue through the distribution of medical equipment and sleep monitoring services. It serves patients with sleep disorders and chronic conditions such as hypertension, diabetes, and obesity. The primary customers are individuals requiring respiratory support and sleep disorder management, particularly those using CPAP devices for OSA treatment. The business model emphasizes specialized medical equipment distribution and personalized patient counseling. SMD Rise PCL's product portfolio includes medical equipment for respiratory systems and sleep monitoring services. The firm provides services such as counseling on CPAP usage and advice for managing sleep disorders. It caters to specific patient segments, including those with OSA, high blood pressure, diabetes, and obesity. The subsidiary Saint Medical Trading Co.,Ltd supports the distribution network for medical supplies and equipment. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

Financial Leverage (Equity Multiplier) of SMD Rise PCL is 1.95 in 2025.

Financial Leverage (Equity Multiplier) of SMD Rise PCL changed from 1.70 to 1.95, representing a 14.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s SMD Rise PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — SMD Rise PCL

All Key Metrics — SMD Rise PCL